Christopher G. Kanakry

Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

Christopher G. Kanakry, Sudipto Ganguly, Marianna Zahurak et al. · Science Translational Medicine · 2013 · 354 citations · Full text

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel et al. · Blood · 2015 · 297 citations · Full text

Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Christopher G. Kanakry, Paul V. O’Donnell, Terry Furlong et al. · Journal of Clinical Oncology · 2014 · 271 citations · Full text

Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression

Lucas P. Wachsmuth, Michael T. Patterson, Michael Eckhaus et al. · Journal of Clinical Investigation · 2019 · 271 citations · Full text

Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

Christopher G. Kanakry, Hua-Ling Tsai, Javier Bolaños‐Meade et al. · Blood · 2014 · 196 citations · Full text